← Leaderboards
Anna S Gukovskaya
Va Greater Los Angeles Healthcare System
$6,581,112
Attributed
$6,581,112
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,716,048 · 8
VA$0 · 4
By mechanism
P01$10,265,581 · 3
R01$3,369,867 · 3
P50$1,080,600 · 2
I01$0 · 2
I21$0 · 1
IK6$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Va Greater Los Angeles Healthcare System
Same institution · by research overlap
- Hidekazu Tsukamoto$41,189,571
Others in their field
Top investigators on “Pancreatitis”
- Mark A Magnuson · Vanderbilt University$67,121,387
- Anirban Maitra · Johns Hopkins University$47,393,016
- Walter N Kernan · Yale University$42,197,025
- Joyce Carol Niland · City Of Hope/Beckman Research Institute$38,277,533
- David Heimbrook · Leidos Biomedical Research, Inc.$36,718,910
- Klaus H. Kaestner · University Of Pennsylvania$34,680,261
Research focus
PancreatitisAcinar CellAutophagocytosisMediatingLysosomesOrganellesPathogenesisCell DeathPathway InteractionsPancreasResponseCellsExocrine PancreasAcute PancreatitisFunctional DisorderImpairmentInflammationGeneticLinkMorbidity - Disease RateEffective TherapyMolecularMouse ModelPathologic
Grant awards (52)
Dysregulated cholesterol homeostasis, caused by lysosomal/autophagy dysfunction, mediates pancreatitis$319,335
R01 · FY2025 · DK · contact PI
Southern California Research Center for ALPD and Cirrhosis$187,151
P50 · FY2025 · AA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Dysregulated cholesterol homeostasis, caused by lysosomal/autophagy dysfunction, mediates pancreatitis$340,623
R01 · FY2024 · DK · contact PI
Southern California Research Center for ALPD and Cirrhosis$152,331
P50 · FY2024 · AA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach$0
I21 · FY2024 · VA · contact PI
Dysregulated cholesterol homeostasis, caused by lysosomal/autophagy dysfunction, mediates pancreatitis$354,816
R01 · FY2023 · DK · contact PI
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach$0
I21 · FY2023 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
Cell Death and Autophagy in Chronic Pancreatitis$0
I01 · FY2021 · VA · contact PI
Cell Death and Autophagy in Chronic Pancreatitis$0
I01 · FY2020 · VA · contact PI
Cell Death and Autophagy in Chronic Pancreatitis$0
I01 · FY2019 · VA · contact PI
Organelle Disorders in Pancreatitis$1,615,130
P01 · FY2018 · DK · contact PI
Dysfunction of Rab GTPases in Pancreatitis$218,434
P01 · FY2018 · DK · contact PI
Cell Death and Autophagy in Chronic Pancreatitis$0
I01 · FY2018 · VA · contact PI
Organelle Disorders in Pancreatitis$1,615,130
P01 · FY2017 · DK · contact PI
Dysfunction of Rab GTPases in Pancreatitis$218,434
P01 · FY2017 · DK · contact PI
Organelle Disorders in Pancreatitis$1,615,130
P01 · FY2016 · DK · contact PI
Dysfunction of Rab GTPases in Pancreatitis$218,434
P01 · FY2016 · DK · contact PI
Inefficient autophagy, mitochondrial dysfunction, and pancreatic tumorigenesis$216,792
P01 · FY2016 · CA · contact PI
Organelle Disorders in Pancreatitis$1,615,130
P01 · FY2015 · DK · contact PI
Dysfunction of Rab GTPases in Pancreatitis$218,434
P01 · FY2015 · DK · contact PI
Inefficient autophagy, mitochondrial dysfunction, and pancreatic tumorigenesis$203,151
P01 · FY2015 · CA · contact PI
Organelle Disorders in Pancreatitis$1,674,416
P01 · FY2014 · DK · contact PI
Dysfunction of Rab GTPases in Pancreatitis$218,434
P01 · FY2014 · DK · contact PI
Inefficient autophagy, mitochondrial dysfunction, and pancreatic tumorigenesis$207,122
P01 · FY2014 · CA · contact PI
Mitochondrial Dysfunction, Permeability Transition Pore, and Acute Pancreatitis$0
I01 · FY2014 · VA · contact PI
'Inefficient autophagy, mitochondrial dysfunction, and pancreatic tumorigenesis$201,411
P01 · FY2013 · CA · contact PI
Mitochondrial Dysfunction, Permeability Transition Pore, and Acute Pancreatitis$0
I01 · FY2013 · VA · contact PI
Apoptosis and Necrosis in Pancreatitis$262,421
R01 · FY2012 · DK · contact PI
'Inefficient autophagy, mitochondrial dysfunction, and pancreatic tumorigenesis$209,999
P01 · FY2012 · CA · contact PI
Mitochondrial Dysfunction, Permeability Transition Pore, and Acute Pancreatitis$0
I01 · FY2012 · VA · contact PI
Apoptosis and Necrosis in Pancreatitis$262,421
R01 · FY2011 · DK · contact PI
Mitochondrial Dysfunction, Permeability Transition Pore, and Acute Pancreatitis$0
I01 · FY2011 · VA · contact PI
Apoptosis and Necrosis in Pancreatitis$265,073
R01 · FY2010 · DK · contact PI
Apoptosis and Necrosis in Pancreatitis$267,750
R01 · FY2009 · DK · contact PI
NADPH oxidase and pancreatic cancer cell survival$72,009
R01 · FY2009 · CA · contact PI
Apoptosis and Necrosis in Pancreatitis$267,750
R01 · FY2008 · DK · contact PI
NADPH oxidase and pancreatic cancer cell survival$72,009
R01 · FY2008 · CA · contact PI
NADPH oxidase and pancreatic cancer cell survival$72,009
R01 · FY2007 · CA · contact PI
Apoptosis and Necrosis in Pancreatitis$176,561
R01 · FY2006 · DK · contact PI
NADPH oxidase and pancreatic cancer cell survival$74,160
R01 · FY2006 · CA · contact PI
Apoptosis and Necrosis in Pancreatitis$180,810
R01 · FY2005 · DK
Apoptosis and Necrosis in Pancreatitis$180,810
R01 · FY2004 · DK
Apoptosis and Necrosis in Pancreatitis$201,310
R01 · FY2003 · DK
PILOT--NON OXIDATIVE ALCOHOL METABOLITES PRIME PANCREAS FOR INFLAMMATORY INJURY$178,517
P50 · FY2002 · AA
PILOT--NON OXIDATIVE ALCOHOL METABOLITES PRIME PANCREAS FOR INFLAMMATORY INJURY$178,517
P50 · FY2002 · AA
PILOT--NON OXIDATIVE ALCOHOL METABOLITES PRIME PANCREAS FOR INFLAMMATORY INJURY$178,517
P50 · FY2001 · AA
PILOT--NON OXIDATIVE ALCOHOL METABOLITES PRIME PANCREAS FOR INFLAMMATORY INJURY$0
P50 · FY2001 · AA
PILOT--NON OXIDATIVE ALCOHOL METABOLITES PRIME PANCREAS FOR INFLAMMATORY INJURY$205,567
P50 · FY2000 · AA